Recent developments in focused library design: targeting gene-families.

Area of Science:

• Drug Discovery
• Medicinal Chemistry
• Chemical Biology

Background:

• Historically, screening libraries prioritized size and diversity, aiming to maximize hits through sheer compound numbers.
• The "bigger is better" strategy, relying on brute-force high-throughput screening (HTS), has largely failed to meet expectations.
• This has led to a shift towards more focused library design approaches.

Purpose of the Study:

• To review the design, selection, and synthesis of gene family-focused or -biased libraries.
• To explore the rationale and emerging trends in developing targeted screening collections.
• To analyze the 'who, what, why, when, and how' of gene family-focused library creation.

Main Methods:

• Review of published literature on gene family-focused library design.
• Analysis of techniques used for library selection and synthesis.
• Examination of reported results from focused library screening.

Main Results:

• A growing trend towards gene family-focused libraries in pharmaceutical and biotechnology markets.
• These libraries reflect a pragmatic approach to managing screening collections and improving HTS efficiency.
• The success of gene family-biased strategies in meeting scientific and business needs is an active research area.

Conclusions:

• Gene family-focused libraries represent a paradigm shift from size- and diversity-driven approaches.
• This trend suggests that manageable, high-quality screening libraries may be more desirable and achievable.
• Further research is needed to fully evaluate the efficacy of gene family-biased strategies in drug discovery.